Clin Mol Hepatol.
2021 Oct;27(4):515-523. 10.3350/cmh.2021.0293.
Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline
- Cho JY1
- Lee YS2
- Kim SS3
- Song DS4
- Lee JH5
- Kim JH
2 - on behalf of the Korean Association for the Study of the Liver1
- Affiliations
-
- 1Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Korea
- 2Department of Internal Medicine, Guro Hospital, Korea University College of Medicine, Seoul, Korea
- 3Department of Gastroenterology, Ajou University School of Medicine, Suwon, Korea
- 4Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea, Seoul, Korea
- 5Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea
- KMID: 2520834
- DOI: http://doi.org/10.3350/cmh.2021.0293
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Management of Patients with Chronic Liver Disease: The Era of the COVID-19 Pandemic
- Response Guidelines for Coronavirus Disease 2019 in Newborn Infants: A 2021 Update
- Management of Traumatic Spinal Fracture in the Coronavirus Disease 2019 Situation
- Assessment and Management of Dysphagia during the COVID-19 Pandemic
- The coronavirus disease 2019 pandemic and chronic diseases
